Register for real-time alerts, custom portfolio, and market movers
Period:
Draw Mode:
| Volume | 0 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Axsome Therapeutics Inc | AXSM | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 71.17 | 04:00:09 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 71.17 |
| Trades | Volume | Avg Volume | 52 Week Range |
|---|---|---|---|
| 0 | 0 | - | 55.02 - 98.40 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| - | 0 | $ 71.17 | USD |
Axsome Therapeutics (AXSM) Options Flow Summary
Axsome Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 3.37B | 47.37M | - | 270.6M | -239.24M | -5.05 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Axsome Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical AXSM Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 69.44 | 74.34 | 65.50 | 69.40 | 710,140 | 1.73 | 2.49% |
| 1 Month | 79.62 | 80.00 | 65.50 | 71.45 | 574,401 | -8.45 | -10.61% |
| 3 Months | 90.53 | 98.40 | 65.50 | 78.35 | 745,362 | -19.36 | -21.39% |
| 6 Months | 63.31 | 98.40 | 55.02 | 75.71 | 711,044 | 7.86 | 12.42% |
| 1 Year | 73.45 | 98.40 | 55.02 | 75.06 | 751,594 | -2.28 | -3.10% |
| 3 Years | 58.625 | 98.40 | 19.38 | 53.81 | 975,123 | 12.55 | 21.40% |
| 5 Years | 16.00 | 125.25 | 13.64 | 54.18 | 882,570 | 55.17 | 344.81% |
Axsome Therapeutics Description
| Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products include AXS-05, AXS-07, AXS-12, and AXS-14. |
